Navigation Links
The Blanchette Rockefeller Neurosciences Institute Identifies Groundbreaking New Therapies for Prevention and Treatment of Alzheimer's Disease
Date:1/11/2011

strains.  BRNI used a difficult training regimen for the mice in order to reveal that significant cognitive deficits occurred five months before plaques were detected in their brains, providing evidence that plaques and tangles are not at the root of the disease.

Treatments of Bryostatin and similar compounds synthesized at BRNI that target the enzyme PKCepsilon, which controls the creation of synapses at the molecular level, were administered for twelve weeks during the study.  While the compounds promoted the growth of new synapses and preservation of existing synapses, they also stopped the decrease of PKCepsilon and the increase of soluble beta amyloid, meaning that the treatments could be used to prevent the familiar hallmarks of Alzheimer's Disease, the plaques and tangles.  BRNI has received approval to move forward with Phase II clinical testing for Bryostatin to treat Alzheimer's Disease, which is set to begin within the next several months.  

The synaptogenic BRNI drugs have also shown potential for the treatment of traumatic brain injury (TBI), as recently reported in the journal Neurobiology of Disease, and stroke described in the Proceedings of the National Academy of Science in 2008 and 2009.

The target of the synaptogenic compounds is the same molecule identified as a biomarker for early diagnosis of Alzheimer's Disease in clinical trials conducted by BRNI and published in Neurobiology of Aging in 2010.  As a result of that study, researchers at the Institute are now working to develop a skin test for identifying Alzheimer's Disease in its early stages before significant progression.  

This study is part of BRNI's ongoing commitment to bridging the gap between fundamen
'/>"/>

SOURCE Blanchette Rockefeller Neurosciences Institute
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Blanchette Rockefeller Neurosciences Institute and Inverness Medical Innovations to Develop Commercial Test to Detect Early Alzheimers Disease
2. Nautilus Neurosciences and Tribute Pharmaceuticals Announce Exclusive Canadian License for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine
3. Nautilus Neurosciences and Mission Pharmacal Announce Exclusive Co-Promotion Agreement for CAMBIA™ (diclofenac potassium for oral solution) for the Acute Treatment of Migraine to the Womens Health Market
4. US WorldMeds Acquires Solstice Neurosciences
5. Intellect Neurosciences, Inc. Announces Independent Studies on Copper Binding Properties of its Lead Candidate OXIGON(TM)
6. Neurosciences Institute Discovers Drug Extends Stroke Treatment Time to 24 Hours, Repairs Brain Tissue
7. Intellect Neurosciences, Inc. and Medical Research Council Technology (U.K.) Reach Important Milestone in Generating an Alzheimers Therapeutic Antibody
8. Knopp Neurosciences Receives Orphan Designation for KNS-760704 for Treatment of ALS
9. Knopp Neurosciences Initiates Phase 1 Clinical Trial of KNS-760704 in ALS Development Program
10. Intellect Neurosciences, Inc. and CHDI, Inc. Enter Into Compound Testing Agreement to Evaluate OXIGON(TM) as a Potential Treatment for Huntington Disease
11. Intellect Neurosciences, Inc. to Present Data on Alzheimers Vaccine at 13th International Congress of Immunology Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/4/2015)... , Sept. 4, 2015  IGI Laboratories, Inc. ... based specialty generic pharmaceutical company, today announced it ... to the U.S. Food and Drug Administration (FDA) of ... submissions now pending at the FDA to twenty-nine. ... the Company, commented, "We believe our current pipeline of ...
(Date:9/4/2015)... Research and Markets ( http://www.researchandmarkets.com/research/gvzjt8/investigation ) has ... Sodium Ibandronate Market, 2010-2019" report to their offering. ... trade name of Bondronat in Germany ... was approved by the FDA to come into the market ... of Boniva. However, since drug makers later developed more convenient ...
(Date:9/4/2015)... MENLO PARK, Calif. , Sept. 4, ... ("DelMar" and the "Company"), a biopharmaceutical company focused on ... announced its financial results for the fiscal year ending ... Company highlights and expected near-term milestones. ... call and live webcast for investors, analysts and other ...
Breaking Medicine Technology:IGI Laboratories, Inc. Announces Seventh ANDA Submission Of 2015 2Investigation Report on China's Sodium Ibandronate Market 2010-2019 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 2DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 3DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 4DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 5DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 6DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 7DelMar Pharmaceuticals Reports Fiscal 2015 Year-End Financial Results and Provides Corporate Update 8
... DIEGO, Jan. 9, 2012   Aethlon Medical, Inc. ... to address infectious disease and cancer, announced that an ... CEO, James A. Joyce, at the Biotech Showcase™ 2012, ... (Photo:  http://photos.prnewswire.com/prnh/20090325/LA88762LOGO-b ) ...
... or the Company) (NASDAQ: HOLX ), a ... medical imaging systems and surgical products dedicated to serving ... Inc.,s (Conceptus) request for an injunction barring future sales ... denied and that no royalty will be due to ...
Cached Medicine Technology:Aethlon Medical Discloses Availability of the Biotech Showcase™ 2012 Presentation 2Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit 2Hologic Announces Denial of Conceptus' Request for Injunction in Patent Infringement Suit 3
(Date:9/4/2015)... ... September 04, 2015 , ... Many consumers are looking for a quick and convenient way to ... The patent-pending K Med Cups provide a quick and simple way to brew a hot ... flu or cough. As a result, they enhance comfort and health. The invention features a ...
(Date:9/4/2015)... ... 2015 , ... The USC Eye Institute is proud to announce that the ... Faculty, residents and staff are honored to have contributed to the success of our ... residency program. Our faculty places a high priority on our educational programs in training ...
(Date:9/4/2015)... ... 04, 2015 , ... Having access to a doctor can sometimes be a ... of unnecessary emergency room visits which affects hospitals’ abilities to provide quality service to ... a solution to alleviate this problem has recently presented itself, the new telemedicine platform ...
(Date:9/4/2015)... ... , ... Lalonde Gordon ran a 44.64 seconds scorcher in the third and ... 400 meters final, with an impressive 44.89 seconds at the 2015 North American, Central ... in August 2015. The 44.64 time is a new NACAC Championship record. , ...
(Date:9/4/2015)... , ... September 04, 2015 , ... ... pale in comparison to settlements under the Stark physician self-referral law. “Stark ... Sept. 17 webinar from Atlantic Information Services, Inc. (AIS), will detail which deals ...
Breaking Medicine News(10 mins):Health News:Redesigned Packaging for Powdered Medicinal Mix Invented by InventHelp® Client (CBA-2637) 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 2Health News:USC Ophthalmology Residency Program Ranked in Top 10 by Doximity 3Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 2Health News:Telemedicine Platform DocChat Announces Launch Offering a Way for Patients to Consult Doctors and Receive Prescriptions 24/7 3Health News:Lalonde Gordon’s Recipe Brings Home the Gold 2Health News:Lalonde Gordon’s Recipe Brings Home the Gold 3Health News:Sept. 17 Webinar to Offer Best Practices for Physician Contracts 2
... lower the level of proof needed for a medic to ... Sir Liam Donaldson. ,Following the inquiry into GP ... weighted in favor of doctors and therefore proposed his plans ... include regular MoT-style checks on medics' abilities. The plans have ...
... announced the launch of a computer game targeted at ... to combat diseases like AIDS.// ,Announced this ... Swahili versions at unicef.org/voy/explore /aids/explore_1360.html, ,Unicef called it ... game that empowers young people to make good life ...
... in the lungs and airways of people with cystic fibrosis. ... in determining how the disease progresses. The proteins were uncovered ... thought to play a role in the body's immune system. ... the immune system's role in cystic fibrosis, a genetic disease ...
... of alcohol abuse can only be tackled by more action ... health minister// voiced support for higher taxes on drinks. ... Health Action on Alcohol Problems (SHAAP) to raise awareness of ... misuse. ,However the SNP and Conservative parties say ...
... the risk of colorectal cancer in laboratory mice which suggested ... cancer in humans, according to a study by Canadian researchers. ... study of 137 mice, saw that animals that were fed ... of developing colorectal cancer than rodents which were given a ...
... high-level meeting, Prime Minister Manmohan Singh Thursday reviewed the ... dengue and called for setting up an early warning ... over 160 people have died this year due to ... of chikungunya, Health Minister Anbumani Ramadoss has disclaimed any ...
Cached Medicine News:Health News:Doctors Protest against Regulation Changes 2Health News:Now A Computer Game To Battle AIDS 2Health News:Proteins in lungs of patients with cystic fibrosis 2Health News:Proteins in lungs of patients with cystic fibrosis 3Health News:Alcohol Abuse Must be solved with Action 2Health News:Colon cancer Linked to low-folate diet 2Health News:Colon cancer Linked to low-folate diet 3
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTC/1Q chairs are recommended for the ... room, static control, health care and ...
... concave seats and standard-sized backrests with ... seats, backrests, armrests, and casters and ... for the following environments: industry, education, ... care and office. • With cast ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
Medicine Products: